Bredt David bought RAPP
February 19, 2026 · Form 4 insider transaction
Bredt David bought 6,000 shares of Rapport Therapeutics, Inc. at $1.80 per share, a transaction worth $10.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,000
Price
$1.80
Total value
$10.8K
InsiderBredt David
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 19, 2026
Filing dateFebruary 19, 2026
Shares owned after393,075
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Transaction involved a cash exercise of options to purchase shares of the Issuer's common stock. No shares of the Issuer's common stock were sold as part of this transaction.